caffeine has been researched along with Child Mental Disorders in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " EBPCS is defined as the management of the VPIs during the perinatal period which would include antenatal counseling with team briefing and share decision making, treat the chorioamnionitis, antenatal MgS04, antenatal steroid, delayed cord clamping/milking, neonatal resuscitation team preparation, prevention of hypothermia, immediate respiratory support with continuous positive airway pressure at delivery room, less invasive surfactant administration, early surfactant with budesonide therapy, support of cardiovascular system, early initiate of probiotics administration, early caffeine, early parenteral and enteral nutrition, promptly initiating antibiotics." | 5.05 | Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants. ( Chen, YT; Chiu, HY; Chu, SM; Lin, HC; Lin, HY; Tsai, ML, 2020) |
| " In the large international Caffeine for Apnea of Prematurity trial, caffeine improved survival without neurodevelopmental disability at 18 months and demonstrated long term safety up to 11 years." | 5.05 | Neurodevelopmental outcomes after neonatal caffeine therapy. ( Grunau, RE; Synnes, A, 2020) |
| "We determined the influence of cumulative dosing of caffeine citrate on the neurodevelopmental outcomes of low birth weight (VLBW) infants at 18-22 months of postmenstrual age." | 1.51 | Higher daily doses of caffeine lowered the incidence of moderate to severe neurodevelopmental disabilities in very low birth weight infants. ( Chouthai, NS; Gupte, A; Kamat, D; Lulic-Botica, M; Ma, MM; Mamilla, D; Patel, B; Ravichandran, S; Sharma, A; Thomas, R, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, HY | 1 |
| Chu, SM | 1 |
| Lin, HY | 1 |
| Tsai, ML | 1 |
| Chen, YT | 1 |
| Lin, HC | 1 |
| Synnes, A | 1 |
| Grunau, RE | 1 |
| Lodha, A | 2 |
| Rabi, Y | 1 |
| Soraisham, A | 1 |
| Dobry, J | 1 |
| Amin, H | 1 |
| Awad, EA | 1 |
| Tang, S | 1 |
| Sahai, A | 1 |
| Bhandari, V | 1 |
| Ravichandran, S | 1 |
| Chouthai, NS | 1 |
| Patel, B | 1 |
| Sharma, A | 1 |
| Gupte, A | 1 |
| Ma, MM | 1 |
| Mamilla, D | 1 |
| Lulic-Botica, M | 1 |
| Thomas, R | 1 |
| Kamat, D | 1 |
2 reviews available for caffeine and Child Mental Disorders
| Article | Year |
|---|---|
Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Budesonide; Caffeine; Central Nervous System Stim | 2020 |
Neurodevelopmental outcomes after neonatal caffeine therapy.
Topics: Animals; Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; D | 2020 |
2 other studies available for caffeine and Child Mental Disorders
| Article | Year |
|---|---|
Does duration of caffeine therapy in preterm infants born ≤1250 g at birth influence neurodevelopmental (ND) outcomes at 3 years of age?
Topics: Caffeine; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Sc | 2018 |
Higher daily doses of caffeine lowered the incidence of moderate to severe neurodevelopmental disabilities in very low birth weight infants.
Topics: Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Female; Humans; Incidence; | 2019 |